Trials / Conditions / Extensive Small Cell Lung Cancer
Extensive Small Cell Lung Cancer
4 registered clinical trials studyying Extensive Small Cell Lung Cancer — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung NCT07083375 | Zhijie Wang | Phase 2 |
| Recruiting | Adebelizumab Combined With Chemotherapy and Radiotherapy Treat ES-SCLC NCT06125041 | Qianfoshan Hospital | Phase 2 |
| Unknown | A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer NCT06406673 | Henan Cancer Hospital | Phase 2 |
| Unknown | A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carbopla NCT04234607 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 3 |